Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01756443
Other study ID # JR-786-GI
Secondary ID SQ-PM-40
Status Completed
Phase Phase 4
First received December 20, 2012
Last updated December 6, 2013
Start date August 2011
Est. completion date January 2013

Study information

Verified date December 2013
Source Cork University Hospital
Contact n/a
Is FDA regulated No
Health authority Ireland: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

Regional anaesthesia has become the cornerstone of multimodal analgesia. With the advent of ultrasound guided nerve blocks regional anaesthesia has achieved both greater efficacy and a better safety profile as the injection of local anaesthetic is performed under direct vision. This has allowed a reduction of the amount of local anaesthetic injected as compared to peripheral nerve stimulation technique . Blockade of sciatic nerve combined with saphenous nerve provides anaesthesia and analgesia for ankle/foot surgeries. Various combinations of local anaesthetics have been used to provide optimal blockade . A mixture of lidocaine with a long acting local anaesthetic is commonly used. This provides a rapid onset of blockade, but of a consistently shorter duration compared to a long acting local anaesthetic alone. We hypothesize that sequential perineural injection of lidocaine and bupivacaine provides similar onset but a longer duration of sensory block compared to the same dose and volume of local anaesthetic mixed in advance.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date January 2013
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients with ASA 1 - 3 status

- scheduled to undergo semi-elective ankle/foot surgery under regional anaesthesia +/- sedation/opioid free general anaesthesia will be recruited

Exclusion Criteria:

- Patients having surgery on the medial aspect of the ankle/ foot

- allergy to local anaesthetics

- coagulopathy

- malignancy or infection in the popliteal area

- significant peripheral neuropathy

- neurologic disorder of the lower extremity

- any other contraindication to sciatic nerve block

- pregnancy

- history of alcohol or drug dependency/abuse (defined as >40 IU/week)

- a history of significant cognitive or psychiatric disorder that may affect patient assessment

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Open Reduction Internal Fixation(ORIF) of Lateral Malleolus

Intervention

Drug:
2% lidocaine/adrenaline and 0.5% bupivacaine


Locations

Country Name City State
Ireland Cork University Hospital Cork

Sponsors (1)

Lead Sponsor Collaborator
Cork University Hospital

Country where clinical trial is conducted

Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative analgesia/duration of block 24 hours No
Secondary onset of block the block will be assessed every 5 minutes from the time of needle withdrawal till complete loss of sensation to touch. 40 minutes No